Blue Jet bets Rs 2,300 crore on Vizag greenfield pharma hub
image for illustrative purpose
Visakhapatnam: BlueJet Healthcare Ltd, one of India’s leading manufacturers of contrast media intermediates used in medical imaging, is set to break ground on a ₹2,300-crore greenfield pharmaceutical manufacturing facility at Rambilli Industrial Park in Anakapalli district near here. The project marks a significant scale-up of India’s specialty pharma and Contract Development and Manufacturing Organisation (CDMO) capabilities.
Spread across over 102 acres near Visakhapatnam, the facility will create new production capacities for contrast media intermediates, high-intensity sweeteners and multipurpose chemistry units. The project will be developed in phases and is targeted to become operational by FY2028–29. It is coming up in close proximity to Jawaharlal Nehru Pharma City at Parawada.
Founded in 1968 as Jet Chemicals Private Limited, Blue Jet Healthcare has evolved into a science-led specialty pharmaceutical and healthcare ingredients company headquartered in Maharashtra. Today, it operates as an integrated CDMO supplying advanced pharmaceutical intermediates, APIs, contrast media intermediates and high-intensity sweeteners to customers across India, Europe, the United States and other global markets. The company is recognised as a leading player in contrast media intermediates and an early pioneer of saccharin manufacturing in India.
Over the years, it has built strong capabilities in process chemistry, manufacturing scale-up and global regulatory-compliant production, positioning itself as a strategic supplier to multinational pharmaceutical companies.
